Manila Bulletin
Galvez: Vaccine supply shortage seen in 1st, 2nd quarter of 2021
Vaccine czar Secretary Carlito Galvez, Jr. warned of a potential COVID-19 vaccine shortage in the Philippines during the first and second quarters of 2021 due to high demand from Europe and the United States.
Despite this anticipated scarcity, Galvez expressed confidence that the Philippines will ultimately secure sufficient vaccine supply to meet its vaccination program goals for the entire year.
The Philippine government has earmarked P73.2 billion for vaccine procurement, with funds sourced from multilateral agencies, domestic funds, and bilateral agreements.
The nation's target is to vaccinate between 50 to 70 million individuals this year, with an initial estimate of 50,000 people to be inoculated in February.
Priority groups for vaccination include frontline health workers, indigent senior citizens, the remainder of the indigent population, and uniformed personnel.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
The Philippines is aiming to complete its COVID-19 vaccination program by 2023, with a possibility of achieving good outcomes by 2022.
Read more →
The Philippines will not lose its 44 million vaccine allocation from the COVAX facility despite a one-week delay in the delivery of Pfizer vaccines.
Read more →
The Philippine government aims to secure enough vaccines for 70 million Filipinos by the end of 2021, despite delays in the first Pfizer-BioNTech shipment from COVAX.
Read more →
The Philippine government is on track to secure 170 million doses of COVID-19 vaccines to inoculate between 50 to 70 million Filipinos this year.
Read more →
The Philippine General Hospital (PGH) is fully prepared for the rollout of COVID-19 vaccines, having met all requirements except for a specific type of syringe.
Read more →